ArticleCancer immunology, immunotherapy : CII2018

Rational combinations of in vivo cancer antigen priming and adoptive T-cell therapy mobilize immune and clinical responses in terminal cancers.

Qing Zhao Ruan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.